Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE

  • Read more about NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE
US Application 17/358,522
Filed on 2021-06-25

EBOLA VIRUS GLYCOPROTEIN-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF

  • Read more about EBOLA VIRUS GLYCOPROTEIN-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF
US Application 17/415,412
Filed on 2021-06-17

Ebola Virus Glycoprotein-Specific Monoclonal Antibodies and Uses Thereof

  • Read more about Ebola Virus Glycoprotein-Specific Monoclonal Antibodies and Uses Thereof
European Patent
19842479.8
Filed on 2019-12-19

Human IgA Monoclonal Antibody That Targets A Conserved Site On The Plasmodium Falciparum Circumsporozoite Protein

  • Read more about Human IgA Monoclonal Antibody That Targets A Conserved Site On The Plasmodium Falciparum Circumsporozoite Protein
Patent Cooperation Treaty
PCT/US2021/037571
Filed on 2021-06-16

POLYMER ADJUVANT

  • Read more about POLYMER ADJUVANT
US Application 16/907,912
Filed on 2020-06-22

MULTIVALENT VACCINES FOR RABIES VIRUS AND CORONAVIRUSES

  • Read more about MULTIVALENT VACCINES FOR RABIES VIRUS AND CORONAVIRUSES
US Application 17/307,066
Filed on 2021-05-04

CONSTRUCTION OF WEST NILE VIRUS AND DENGUE VIRUS CHIMERAS FOR USE IN A LIVE VIRUS VACCINE TO PREVENT DISEASE CAUSED BY WEST NILE VIRUS

  • Read more about CONSTRUCTION OF WEST NILE VIRUS AND DENGUE VIRUS CHIMERAS FOR USE IN A LIVE VIRUS VACCINE TO PREVENT DISEASE CAUSED BY WEST NILE VIRUS
Australia
2021203089
Filed on 2021-05-14

RECOMBINANT METAPNEUMOVIRUS F PROTEINS AND THEIR USE

  • Read more about RECOMBINANT METAPNEUMOVIRUS F PROTEINS AND THEIR USE
US Patent 11,786,591
Filed on 2021-05-18

Development Of Dengue Virus Vaccine Components

  • Read more about Development Of Dengue Virus Vaccine Components
Australia
2021202950
Filed on 2021-05-10

RSV VACCINE BEARING ONE OF MORE P GENE MUTATIONS

  • Read more about RSV VACCINE BEARING ONE OF MORE P GENE MUTATIONS
Patent Cooperation Treaty
PCT/US2021/032305
Filed on 2021-05-13

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 173
  • Page 174
  • Page 175
  • Page 176
  • Page 177
  • Page 178
  • Page 179
  • Page 180
  • Page 181
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health